Alkermes (ALKS) Tops Q2 EPS by 6c: Boosts FY13 Outlook
Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.17, $0.06 better than the analyst estimate of $0.11. Revenue ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)